Physician profile
Nathan D Lott
NPI 1124291000
$9,885.43
in general payments reported to CMS, 2019-2025
20 companies · $7,775 in 2025
The $7,775 reported for 2025 was more than what 91% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $147 · 2022: $302 · 2023: $896 · 2024: $515 · 2025: $7,775.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Travel and Lodging: $2,288 · Food and Beverage: $1,397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Travel and Lodging | $2,288.34 |
| Food and Beverage | $1,397.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,363.51 | 2023-2025 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $433.03 | 2019-2025 | Tezspire, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $244.96 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Inari Medical, INC. | $152.89 | 2022 | |
| Abiomed | $120.54 | 2023 | Impella |
| Janssen Pharmaceuticals, INC | $87.89 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $84.61 | 2019-2024 | Ofev |
| Genzyme Corporation | $72.23 | 2019-2024 | |
| Janssen Scientific Affairs, LLC | $64.67 | 2023 | Xarelto |
| Sunovion Pharmaceuticals INC. | $46.67 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $42.88 | 2019-2024 | Dupixent |
| Amgen INC. | $34.96 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $27.12 | 2019-2025 | Winrevair |
| Tactile Systems Technology INC | $20.85 | 2024 | Flexitouch Plus, Entre Plus |
| United Therapeutics Corporation | $20.59 | 2024 | Tyvaso |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Respiratory, INC | $16.04 | 2019 | |
| Olympus America INC. | $14.82 | 2025 | Single Use Aspiration Needle Na-U401sx |
| Philips North America LLC | $14.10 | 2019 | |
| Grifols USA, LLC | $11.87 | 2019 | |
| Lilly USA, LLC | $11.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Lott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.